Role
The CWG formed to work on the co-design of an Enhanced Consumer Engagement Process. This is one of the main commitments in the 2022–2027 Strategic Agreement (clause 6.3.2) as part of improving health technology assessment. This co-design process aimed to improve how we include consumer and patient perspectives during the medicines listing process.
The CWG:
- found opportunities along the health technology pathway where consumer engagement may inform and improve HTA committees’ decision-making processes
- developed these into proposed recommendations for enhanced consumer engagement
- held open consumer and other stakeholder consultations for feedback on the proposed recommendations
- decided on final recommendations for an enhanced consumer engagement process informed by the consultation feedback
- created a final report with their recommendations.
Members
We chose members after an expression of interest process for consumer representatives. The group includes a range of consumer, industry and department representatives.
Member | Role |
---|---|
Sharon Winton (Chair) | Consumer representative |
Genevieve Handley | Consumer representative |
Nicole Millis | Consumer representative |
Cara Philpott | Consumer representative |
Karen van Gorp | Consumer representative |
Hayley Andersen | Industry representative |
Petrina Keogh | Industry representative |
Liz Marshall | Department representative |
Rebecca Pitman | Department representative |
Meetings
The CWG held different workshops scheduled between November 2023 to June 2024. These were to:
- design and develop recommendations for the co-designing process
- prepare the consultation
- review consultation feedback
- create the report of recommendations for the enhanced consumer engagement process.
Read the CWG communiques for more details about their activities.